BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 28, 2000
View Archived Issues
Bioenvision to codevelop clofarabine for leukemia; mode of action examined at UCSD
Read More
Proteomics collaboration between Myriad Genetics and Bayer extended and expanded
Read More
Orphan grants Kirin Brewery marketing and distribution rights to Busulfex for Asia
Read More
Pharmaccine collaboration between Oxxon Pharmaccines and Ludwig Institute
Read More
Competitive metabotropic glutamate receptor antagonist with some selectivity for mglu5 subtype
Read More
ArQule and Acadia join forces in GPCR-targeted drug discovery
Read More
OSI Pharmaceuticals reviews progress during the year
Read More
Cubist completes enrollment in phase III skin & soft tissue infection trial
Read More
Highly selective tracer for mapping brain A2A receptors discovered by Kyowa Hakko
Read More
Merck KGaA establishes Merck Pharma in Italy through acquisition
Read More
Applied Molecular Evolution and Biosynexus to optimize antibacterial agent
Read More
Combination tgDCC-E1A/radiation therapy enters phase II
Read More
Meiji Milk and Takeda to codevelop MT-201 for treatment of cryptomeria pollinosis
Read More
Lilly and Sankyo to collaborate on CS-747 development
Read More
Advanced Magnetics submits sNDA for Feridex I.V. contrast agent
Read More
FDA approves Botox for cervical dystonia
Read More
R.W. Johnson seeks FDA approval for transdermal contraceptive
Read More
Celgene's NDA for d-MPH accepted for review by FDA
Read More
GlaxoSmithKline now listed on London and N.Y. stock exchanges
Read More
Otsuka reveals thiazole derivatives with potential broad therapeutic application
Read More
Takeda discloses compounds with potent adenosine A3 receptor-antagonist activity
Read More
Japan Science and Technology Corporation's unique compounds for diabetes and hypertension therapy
Read More
N-Aryl-alkylamides for CNS disorders claimed by Warner-Lambert
Read More
Arylamidines and cyclic amidines with broad clinical application reported by Merck & Co.
Read More
